missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human CCL4/MIP-1 beta Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marca: R&D Systems™ 271-BME-050
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
The Recombinant Human CCL4/MIP-1 beta Protein is derived from E. coli. The Recombinant Human CCL4/MIP-1 beta Protein has been validated for the following applications: Bioactivity.
Especificaciones
| Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. | |
| 7.8 kDa & 7.3 kDa | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
| 6351 | |
| CCL4/MIP-1 beta | |
| E. coli-derived human CCL4/MIP-1 beta protein Ala24-Asn92 (major); Pro30-Asn92 (Minor) | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
R&D Systems™ Recombinant Human CCL4/MIP-1 beta Protein > 50ug
Spot an opportunity for improvement?Share a Content Correction